AVAI BIO, INC. (AVAI) stock: key figures, P/E, revenue and dividend
Information Technology · United States
AVAI BIO, INC. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Operating income | -1.14 m USD | -1.75 m USD |
| EBIT | -1.14 m USD | -1.75 m USD |
| Net income | -1.14 m USD | -1.75 m USD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AVAI BIO, INC.
Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies. It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources. It also offers Avant! AI, a platform that has shown impressive results related to the technology's usage, access, and performance; and InstantFAME. The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026. Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.
More stocks
- BioCardia, Inc. (BCDA)
- PCS Edventures!, Inc. (PCSV)
- SPAR Group, Inc. (SGRP)
- TAITRON COMPONENTS INC (TAIT)
- Adia Nutrition, Inc. (ADIA)
- Magnolia Bancorp, Inc. (MGNO)
- Trutankless, Inc. (TKLS)
- INNSUITES HOSPITALITY TRUST (IHT)
- GLEN BURNIE BANCORP (GLBZ)
- Anebulo Pharmaceuticals, Inc. (ANEB)
- VerifyMe, Inc. (VRME)
- LeonaBio, Inc. (LONA)
Not investment advice. All data without warranty, price as of 18.11.2026. Details in the risk notice.